Florida Says Can Do To Medical Cannabis

by Akerman LLP - Health Law Rx
Contact

In the waning days of the 2014 legislative session, the Florida Legislature passed the Compassionate Medical Cannabis Act of 2014.  It is a very limited medical marijuana bill with very strict restrictions and conditions on use.  The bill allows access to only low-THC (tetrahydrocannabinol) cannabis (so-called "Charlotte's Web") for persons with cancer or another condition that produces seizures or severe and persistent muscle spasms.  Only physicians who are medical doctors (M.D.) or osteopathic doctors (D.O.) may order the low-THC cannabis for patients.

Among the bill's highlights are:

  • Medical use does not include smoking but can include vaporizing;
  • Patients must be Florida residents and added to a "compassionate use registry" by their physician;
  • Physicians may order this drug for these patients beginning January 1, 2015 if
    • Patient is a Florida resident;
    • Physician has completed an 8-hour course on medical marijuana and passed an examination which must be retaken at license renewal;
    • Physician has treated the patient for one of the above conditions and "no other satisfactory alternative treatment options exist"
    • Physician determines the risks to patient are reasonable in light of potential benefits;
    • For patients under 18 years old, a second physician concurs and the concurrence is documented in the patient record;
    • Physician registers as an orderer on the compassionate use registry and lists the contents of each order on such registry;
    • Physician inactivates patient's compassionate use registration when treatment is discontinued;
    • Physician maintains a treatment plan to include dose, route of administration; planned duration, and monitoring of symptoms and reactions to treatment;
    • Physician submits the treatment plan to the University of Florida College of Pharmacy quarterly for research;
    • Physician obtains informed consent for the treatment;

The Florida Department of Health must establish an Office of Compassionate Use to regulate the medical marijuana procedures, including a secure online registry accessible to law enforcement and dispensing organizations. Up to 5 dispensing organizations – one for each region of the state – may be approved by the Department of Health in order to cultivate, process, and dispense  low-THC cannabis.  The dispensing organizations must:

  • receive approval from the Florida Department of Health;
  • employ a medical director who has completed a 2-hour course and examination;
  • possess a valid certificate of registration issued by the Department of Agriculture and Consumer Services that is issued for the cultivation of more than 400,000 plants, be operated by a nurseryman, and have been operated as a nursery continuously for 30 years;
  • have the ability to secure the premises and maintain accountability of the marijuana;
  • have an infrastructure to dispense the low-THC cannabis;
  • have the financial ability to operate for two years and post a $5 million dollar bond; and
  • pass background checks on owners and managers.

A physician commits a first-degree misdemeanor if he or she orders low-THC cannabis for a patient without a reasonable belief that the patient is suffering from cancer or another condition that produces seizures or severe and persistent muscle spasms. 

Persons who fake an illness for the purpose of obtaining low-THC cannabis also commit a first-degree misdemeanor.

The bill also authorizes universities to conduct research on low-THC cannabis without violating drug laws.
 
Governor Scott is expected to sign the bill within the next few weeks. Although the bill allows physicians to begin ordering the low-THC cannabis on January 1, 2015, it is not clear if the Florida Department of Health will complete the rulemaking process to establish the Compassionate Use Registry and approve dispensing organizations by that date.  In the meantime, Florida voters will decide in November whether to more broadly legalize medical marijuana for the treatment of other medical conditions.

 

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Akerman LLP - Health Law Rx | Attorney Advertising

Written by:

Akerman LLP - Health Law Rx
Contact
more
less

Akerman LLP - Health Law Rx on:

Readers' Choice 2017
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up using*

Already signed up? Log in here

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
Privacy Policy (Updated: October 8, 2015):
hide

JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources. Our policies with regard to data collection and use of personal information of users of the Service, regardless of the manner in which users access the Service, and visitors to the Website are set forth in this statement ("Policy"). By using the Service, you signify your acceptance of this Policy.

Information Collection and Use by JD Supra

JD Supra collects users' names, companies, titles, e-mail address and industry. JD Supra also tracks the pages that users visit, logs IP addresses and aggregates non-personally identifiable user data and browser type. This data is gathered using cookies and other technologies.

The information and data collected is used to authenticate users and to send notifications relating to the Service, including email alerts to which users have subscribed; to manage the Service and Website, to improve the Service and to customize the user's experience. This information is also provided to the authors of the content to give them insight into their readership and help them to improve their content, so that it is most useful for our users.

JD Supra does not sell, rent or otherwise provide your details to third parties, other than to the authors of the content on JD Supra.

If you prefer not to enable cookies, you may change your browser settings to disable cookies; however, please note that rejecting cookies while visiting the Website may result in certain parts of the Website not operating correctly or as efficiently as if cookies were allowed.

Email Choice/Opt-out

Users who opt in to receive emails may choose to no longer receive e-mail updates and newsletters by selecting the "opt-out of future email" option in the email they receive from JD Supra or in their JD Supra account management screen.

Security

JD Supra takes reasonable precautions to insure that user information is kept private. We restrict access to user information to those individuals who reasonably need access to perform their job functions, such as our third party email service, customer service personnel and technical staff. However, please note that no method of transmitting or storing data is completely secure and we cannot guarantee the security of user information. Unauthorized entry or use, hardware or software failure, and other factors may compromise the security of user information at any time.

If you have reason to believe that your interaction with us is no longer secure, you must immediately notify us of the problem by contacting us at info@jdsupra.com. In the unlikely event that we believe that the security of your user information in our possession or control may have been compromised, we may seek to notify you of that development and, if so, will endeavor to do so as promptly as practicable under the circumstances.

Sharing and Disclosure of Information JD Supra Collects

Except as otherwise described in this privacy statement, JD Supra will not disclose personal information to any third party unless we believe that disclosure is necessary to: (1) comply with applicable laws; (2) respond to governmental inquiries or requests; (3) comply with valid legal process; (4) protect the rights, privacy, safety or property of JD Supra, users of the Service, Website visitors or the public; (5) permit us to pursue available remedies or limit the damages that we may sustain; and (6) enforce our Terms & Conditions of Use.

In the event there is a change in the corporate structure of JD Supra such as, but not limited to, merger, consolidation, sale, liquidation or transfer of substantial assets, JD Supra may, in its sole discretion, transfer, sell or assign information collected on and through the Service to one or more affiliated or unaffiliated third parties.

Links to Other Websites

This Website and the Service may contain links to other websites. The operator of such other websites may collect information about you, including through cookies or other technologies. If you are using the Service through the Website and link to another site, you will leave the Website and this Policy will not apply to your use of and activity on those other sites. We encourage you to read the legal notices posted on those sites, including their privacy policies. We shall have no responsibility or liability for your visitation to, and the data collection and use practices of, such other sites. This Policy applies solely to the information collected in connection with your use of this Website and does not apply to any practices conducted offline or in connection with any other websites.

Changes in Our Privacy Policy

We reserve the right to change this Policy at any time. Please refer to the date at the top of this page to determine when this Policy was last revised. Any changes to our privacy policy will become effective upon posting of the revised policy on the Website. By continuing to use the Service or Website following such changes, you will be deemed to have agreed to such changes. If you do not agree with the terms of this Policy, as it may be amended from time to time, in whole or part, please do not continue using the Service or the Website.

Contacting JD Supra

If you have any questions about this privacy statement, the practices of this site, your dealings with this Web site, or if you would like to change any of the information you have provided to us, please contact us at: info@jdsupra.com.

- hide
*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.